Tavapadon Treatment for Early Parkinson Disease

Name: Tavapadon Treatment for Early Parkinson Disease: Findings from the TEMPO Trials
Uploaded: 2026-09-28T04:00:00+00:00
Duration: 16 min 59 s
Description: Hubert Fernandez, MD, Cleveland Clinic, Cleveland, OH, discusses findings from the TEMPO trials evaluating tavapadon, a selective dopamine D1/D5 receptor p

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

An Update on Devices for Essential Tremor Treatment
An Update on Devices for Essential Tremor Treatment
SEP-OCT 2026 ISSUE
An Update on Devices for Essential Tremor Treatment
Mackenzie R. Paller-Moore, MD; Katelynn Getchell, MD
Mackenzie R. Paller-Moore, MD; Katelynn Getchell, MD
Wearable Devices in Parkinson Disease: A Practical Guide for Clinicians
Wearable Devices in Parkinson Disease: A Practical Guide for Clinicians
SEP-OCT 2026 ISSUE
Wearable Devices in Parkinson Disease: A Practical Guide for Clinicians
Siegfried Hirczy, MD; Ruth B. Schneider, MD
Siegfried Hirczy, MD; Ruth B. Schneider, MD
The New Era of Deep Brain Stimulation Programming in Parkinson Disease
The New Era of Deep Brain Stimulation Programming in Parkinson Disease
Movement Disorders
The New Era of Deep Brain Stimulation Programming in Parkinson Disease
Aparna Wagle Shukla, MD
Aparna Wagle Shukla, MD
Bill Nye on Ataxia, Family Risk, and the Search for Answers
Bill Nye on Ataxia, Family Risk, and the Search for Answers
Movement Disorders
Bill Nye on Ataxia, Family Risk, and the Search for Answers
Bill Nye; Lauren Moore, PhD
Bill Nye; Lauren Moore, PhD